Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|July 19, 2017
Dysregulation of BCL-2 family proteins by leukemia fusion genesLauren M Brown, Diane T Hanna, Seong L Khaw, et al.
Pediatric Blood & Cancer|June 26, 2007
Temozolomide in pediatric low-grade gliomaSeong L Khaw, Lee T Coleman, Peter A Downie, et al.
Pediatric Blood & Cancer|December 8, 2005
Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamideSeong L Khaw, Peter A Downie, Keith D Waters, et al.
Pediatric Blood & Cancer|June 29, 2019
Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemiaLauren M Brown, Ray C Bartolo, Nadia M Davidson, et al.
Blood Advances|January 21, 2022
SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemiaLauren M Brown, Soroor Hediyeh-Zadeh, Teresa Sadras, et al.
Blood|April 28, 2012
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cellsDelphine Mérino, Seong L Khaw, Stefan P Glaser, et al.
Blood Advances|June 23, 2020
Cotargeting BCL-2 and MCL-1 in high-risk B-ALLDonia M Moujalled, Diane T Hanna, Soroor Hediyeh-Zadeh, et al.
Nature Communications|November 28, 2018
VDAC2 enables BAX to mediate apoptosis and limit tumor developmentHui San Chin, Mark X Li, Iris K L Tan, et al.
Pediatric Blood & Cancer|April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid LeukaemiaSeth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Pageof 1